B-Cell Neoplasia

Paolo Ghia

Paolo Ghia

Email: ghia.paolo@hsr.it
Location: DIBIT1, Floor 1, Room 38
Group Leader, B-cell Neoplasia
Head, Strategic research program on CLL
Full Professor in Medical Oncology, Università Vita Salute San Raffaele

Paolo Ghia received his MD from the University of Torino, followed by a residency in Internal Medicine. He received his PhD working at the Basel Institute for Immunology, Basel, Switzerland, studying the development of normal human B lymphocytes. He moved to the Dana-Farber Cancer Institute, Harvard Medical School, Boston, where he studied the molecular mechanisms of the pathogenesis of chronic lymphoproliferative disorders, particularly of follicular lymphoma. He is now Full Professor in Medical Oncology at the Università Vita-Salute San Raffaele and Head of the Laboratory of B-Cell Neoplasia at the affiliated IRCCS Ospedale San Raffaele. He is Director of the Strategic Research Program on CLL, a clinical Unit at the hospital, where he acts as National Coordinator or Principal Investigator in Phase 1-3 clinical trials in CLL. He is the President of the European Research Initiative on CLL (ERIC), the largest Europe-based academic non-profit network of scientists dedicated to the improvement of CLL patients care through research; he is co-chairman of the Working Party on lymphoproliferative diseases of GIMEMA (Italian Group of Adult Hematologic Malignancies); he is Treasurer of the international workshop on CLL (iwCLL), the section editor for CLL at Hemasphere, the official journal of EHA, and a co-author of the ESMO Guidelines on the management of CLL.

Click here to view our publications